Atlas Trials

A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101

Clinical trial NCT04655911 · TERMINATED

Trial details

NCT number
NCT04655911
Sponsor
Abeona Therapeutics, Inc
Status
TERMINATED
Study type
OBSERVATIONAL
Mucopolysaccharidosis III-B
Start date
2020-10-28
Primary completion
2022-04-07
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.